← Back
$PLSE All transactions

PULSE BIOSCIENCES, INC.

M 10b5-1 Plan

$ Value

$0

Shares

20,000

Price

$0

Filed

Sep 22

Insider

Name

Danahy Kevin Patrick

Title

Chief Commercial Officer

CIK

0001913245

Roles

Officer

Transaction Details

Transaction Date

2025-09-18

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

430,000

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025. | The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. | Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022.

Filing Info

Accession No.

0001437749-25-029646

Form Type

4

Issuer CIK

0001625101

Danahy Kevin Patrick's History

Date Ticker Type Value
2026-02-18 PLSE M $8K
2026-02-18 PLSE $118K
2026-02-18 PLSE M $0
2026-02-17 PLSE M $31K
2026-02-17 PLSE $473K
2026-02-17 PLSE M $0
2026-02-13 PLSE M $31K
2026-02-13 PLSE $471K
2026-02-13 PLSE M $0
2026-02-12 PLSE M $31K

Other Insiders at PLSE (90d)

Insider Bought Sold Last
UECKER DARRIN
Chief Technology Officer
2026-03-23
Sainz Maria 2026-02-05
Danahy Kevin Patrick
Chief Commercial Officer
$2.9M 2026-02-18